Loading...
Back to narrative

507717: New Formulation Plant Decision Will Drive Next Wave Of Expansion

Update shared on 17 Nov 2025

Fair value Decreased 7.97%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-18.4%
7D
-7.3%

Analysts have lowered their price target for Dhanuka Agritech from ₹1,779.88 to ₹1,638.00. This reflects tempered expectations for future revenue growth and profit margins.

What's in the News

  • Dhanuka Agritech has scheduled a Board Meeting on October 31, 2025, at 11:00 IST (Key Developments)
  • The Board will review and approve the company's financial results for the quarter and half-year ended September 30, 2025 (Key Developments)
  • The agenda also includes consideration of a land purchase in Nagpur, Maharashtra, for setting up a new formulation plant (Key Developments)

Valuation Changes

  • The consensus analyst price target has fallen from ₹1,779.88 to ₹1,638.00, reflecting a more cautious outlook.
  • The discount rate has decreased slightly from 13.43% to 13.34%, indicating lower perceived risk.
  • The revenue growth expectation has declined from 15.52% to 13.97%.
  • The net profit margin projection is down from 14.17% to 13.64%.
  • The future P/E has risen slightly from 25.40x to 26.39x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.